Demand For Global In Vivo Toxicology Testing Market Size & Share to Surpass USD 7.54 Billion by 2028, Exhibit a CAGR of 6.3% | Industry Trends, Growth, Value, Segment Analysis & Forecast Report by Zion Market Research
NEW YORK, June 28, 2022 /PRNewswire/ -- As per Zion Market Research study, The global in-vivo toxicology market grasped a revenue growth of USD 5.23 billion in 2021 and is projected to grow to around USD 7.54 billion by 2028 at a CAGR rate of 6.3 percent over the forecast period.
Key Industry Insights & Finding of the In Vivo Toxicology Testing Market Reports:
- As per the analysis shared by our research analyst, the In Vivo Toxicology Testing Market is expected to grow annually at a CAGR of around 6.3 % (2022-2028).
- Through the primary research, it was established that the In Vivo Toxicology Testing Market was valued approximately USD 5.23 Billion in 2021 and is projected to reach to roughly USD 7.54 Billion by 2028.
- There is a growing trend of biomedical research and preclinical activities by CROs happening in this region which makes it the most dominating North America region for the in-vivo toxicology market.
- Asia Pacific region also trails as the second-largest share of the market due to the significant growth opportunities for pharmaceutical firms in this region.
- The growing geriatric population along with qualified researchers and low-cost operations in this region are supporting factors of market growth.
- The focus on bringing the attrition rate of failing molecules in the early stages has become more significant and there is a considerable increase in the leverage of in-vivo testing.
Zion Market Research published the latest report titled as "In Vitro Toxicology Testing Market By Technology (Proteomics, Toxicogenomics, High-Throughput Technologies, Transcriptomics, OMICS Technologies, Molecular Imaging Technologies, Metabolomics, Genomics, And Cell Culture Technology), By Product (Issue Culture Assays, Enzyme Toxicity Assays, Reagents & Labware, Cell-Based ELISA And Western Blots, Services, Bacterial Toxicity Assays, Assays Receptor Binding Assays, And Other Assays), By Industry (Oral Fluid Screening, Diagnostics, Chemical Industry, Hair Screening, Cosmetics & Household Products, Alcohol Screening, Pharmaceutical Industry, Food Industry, Urine Screening, And Other Diagnostics): Global Industry Perspective, Comprehensive Analysis And Forecast, 2020 – 2028." into their research database.
In Vivo Toxicology Testing Market : Overview
The toxic effect of chemicals is examined on non-human living organisms which are basically called as In-Vivo Toxicology. The cytotoxicity tests actually expose the adverse effects of the drug in living organisms. Before it could be tested on humans, it is tested on organisms or animals to identify the effect of a drug. Many animals are used for testing such as guinea pigs, rodents, rabbits, and others. They are also injected by different ways of exposure. The prominent ones are intravenous, topical, intramuscular, and others.
These tests are done on the isolated organs or parts of the animals. Most hazardous chemical substances actually go through validation in this process even during the early stages of the drug development. The safety evaluation of the drug along with its ranking as a potential drug is done through in-vivo toxicology testing. It includes a total evaluation of all the responses put together like absorption, distribution, metabolism, excretion, dose-response, and threshold response of the drug. Various industries use them on a frequent basis like pharmaceuticals, chemicals, and the food industry. Many research and development organizations also use these kinds of tests on the organisms on a regular basis.
These tests also have the capacity to expose the presence of cultured bacteria or any alien infections in the body. Sometimes, not just the harmful effects of drugs are being exposed, but also the deficiency or toxic properties infested in the organism are identified. The resultant product could be anything ranging from treatment drugs to any agricultural chemicals or even general food additives.
Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.zionmarketresearch.com/sample/in-vitro-toxicology-testing-market
Our Free Sample Report Includes:
- 2022 Updated Report Introduction, Overview, and In-depth industry analysis
- COVID-19 Pandemic Outbreak Impact Analysis Included
- 222 + Pages Research Report (Inclusion of Updated Research)
- Provide Chapter-wise guidance on Request
- 2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
- Includes Updated List of tables & figures
- Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
- Zion Market Research methodology
Industry Dynamics:
In Vivo Toxicology Testing Market : Growth Drivers
- Recent innovations in pharmaceutical and biotechnology industries along with rising focus on personalized medications to propel the market growth
Recent innovations in human cell culture, as well as test systems, instigates an expansion of the market. These tests are predictive, demonstrative, and extremely suitable for screening nanomaterials and airborne materials which makes them a leveraging aspect of drug validation for the companies.
The pharmaceutical and biotechnology industries are keen on developing drug products that have real value rather than some immediate benefits. Hence many innovations in testing methods have been on the rise and serious validation based on its real outcome has been deemed important. This increases the demand for in-vivo toxicology testing in all medical industries thereby propelling market growth considerably.
The focus on bringing the attrition rate of failing molecules in the early stages has become more significant and there is a considerable increase in the leverage of in-vivo testing. An increase in the innovations of animal model testing coupled with rising in the focus on personalized medications also triggers market growth.
There is also an eminent increase in clinical trials which contributes to the growth of the global in-vivo toxicology market. Oncology research along with humanized animal models testing has gained traction which is fueling the market growth in huge proportions. The increase in funding of small biotech firms and small-scale start-ups in pharmaceutical sectors induce market growth as well.
There has also been a considerable rise in the development of toxic substances and dosage testing which has increased the demand for in-vivo testing. Apart from this, this testing has been adopted in various sectors such as pharmaceutical, chemicals, biotechnology firms, cosmetics, and household products.
In Vivo Toxicology Testing Market : Restraints
- Availability of alternate methods of testing to animal testing and growing contempt against animal testing hampers the market growth.
Animal welfare communities have increased the pressure of contention against animal testing. This has triggered the research scientists and toxicology experts to come up with new methods of alternative testing methods. This impedes market growth to a large extent. In-vitro testing as an alternative has been blooming in recent times and many mainstream companies have adopted that testing method to reduce animal use in toxicology studies. This factor invariably limits the demand for animal model testing proportionally.
Directly Purchase a Copy of the Report @ https://www.zionmarketresearch.com/buynow/su/in-vitro-toxicology-testing-market
In Vivo Toxicology Testing Market: Opportunities
- The increasing trend of humanized animal model testing in preclinical research provides a lucrative opportunity for market growth.
Humanized animal models gained from human cells or tissues have been used rapidly in biotechnology firms. The actual effects of drugs on humans are being estimated by this method which is also deemed to be more precise than any other testing method. They also expose any kind of human-specific infections, and therapies that cure them as well. This factor actually increases the demand and leverage of in-vivo toxicology testing. An increase in oncology research and focus on personalized medicines provide opportunities for the global in-vivo toxicology market expansion.
In Vivo Toxicology Testing Market: Challenges
- Government regulations against harming animals for medical testing pose a challenge for the market growth
There has been an increase in the regulations and laws regarding the ethical use of animals in research which instigates the scientists to look for alternative methods of testing. There are also loopholes in animal testing which affect the accuracy and efficacy of the results. All these factors pose a challenge to market growth.
Chronic test type segment in in-vivo testing has increased because of the growing chronic diseases which pose a challenge for the market
In-vivo toxicology is segmented as acute, sub-acute, sub-chronic test types. This has been used rapidly because of the increasing spread of chronic diseases in the geriatric population. This has increased the leverage and demand for in-vivo testing which triggers large-scale employment of the testing equipment and faculties. This poses a challenge for the market to satisfy this massive demand for in-vivo testing.
Global In Vivo Toxicology Testing Market : Segmentation
- The global In-vivo toxicology in this research analysis is divided into product types, testing types, toxicity endpoints, testing facilities, end-user, and regions.
The product types are classified as instruments, animal models, and reagents & kits. The testing types are divided into chronic toxicity testing, sub-chronic toxicity testing, sub-acute toxicity testing, and acute toxicity testing. The toxicity endpoints are immunotoxicity and systemic. The testing facilities are outsourced and in-house. End-users comprise academic institutes, research institutes, and CROs.
Get More Insight before Buying@ : https://www.zionmarketresearch.com/inquiry/in-vitro-toxicology-testing-market
List of Key Players of In Vivo Toxicology Testing Market :
- Charles River Laboratories
- The Jackson Laboratory
- Envigo
- Taconic Biosciences
- Janvier Labs
- Thermo Fisher Scientific
- Danaher Corporation
- Waters Corporation
- Agilent Technologies
- Shimadzu Corporation
- Bruker Corporation
- PerkinElmer
- MerckkgaA
- GE Healthcare
- Bio-Rad laboratories
- genOway
- Cyagen Biosciences
- GVK BIO
- Polygene
- Crown Biosciences
- Transcure Bioservices
- Harbour BioMed.
Key questions answered in this report:
- What are the growth rate forecast and market size for In Vivo Toxicology Testing Market ?
- What are the key driving factors propelling the In Vivo Toxicology Testing Market forward?
- What are the most important companies in the In Vivo Toxicology Testing Market Industry?
- What segments does the In Vivo Toxicology Testing Market cover?
- How can I receive a free copy of the In Vivo Toxicology Testing Market sample report and company profiles?
Report Scope:
Free Brochure: https://www.zionmarketresearch.com/requestbrochure/in-vitro-toxicology-testing-market
Recent Developments
- In March 2020, GenOway acquired exclusive worldwide rights from Merck for its foundational CRISPR/Cas9 portfolio in the rodent field.
- In July 2020, Taconic entered into an agreement with the University of Texas Medical Branch to distribute humanized ACE2 mice for COVID-19 research.
- In December 2020, the Jackson Laboratory started the production of ACE2 mice to support the research on COVID-19.
Regional Dominance:
- Growing trend of biomedical research and preclinical activities.
North America is the largest share of the global in-vivo toxicology market. This is due to the presence of major players in the in-vivo toxicology market. There is a growing trend of biomedical research and preclinical activities by CROs happening in this region which makes it the most dominating region for the in-vivo toxicology market. Asia Pacific region also trails as the second-largest share of the market due to the significant growth opportunities for pharmaceutical firms in this region. The growing geriatric population along with qualified researchers and low-cost operations in this region are supporting factors of market growth.
Global In Vivo Toxicology Testing Market is segmented as follows:
In Vivo Toxicology Testing Market : By Product Type Outlook (2022-2028)
- Instruments
- Animal Models
- Reagents & Kits
In Vivo Toxicology Testing Market : By Testing Types Outlook (2022-2028)
- Chronic Toxicity Testing
- Sub-Chronic Toxicity Testing
- Sub-acute Toxicity Testing
- Acute Toxicity Testing
In Vivo Toxicology Testing Market : By Toxicity Endpoints Outlook (2022-2028)
- Immunotoxicity
- Systemic
In Vivo Toxicology Testing Market : By Testing Facility Outlook (2022-2028)
- Outsourced
- In-house
In Vivo Toxicology Testing Market : By End-user Outlook (2022-2028)
- Academic Institutes
- Research Institutes
- CRO's
In Vivo Toxicology Testing Market : By Region Outlook (2022-2028)
North America
- The U.S.
- Canada
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Press Release For In Vivo Toxicology Testing Market : https://www.zionmarketresearch.com/news/global-in-vivo-toxicology-testing-market
Browse Other Related Research Reports from Zion Market Research
- Medical Enzyme Technology Market - Global Industry Analysis: The global Medical Enzyme Technology market accrued earnings worth approximately 4.5(USD Billion) in 2020 and is predicted to gain revenue of about 6.7(USD Billion) by 2028, is set to record a CAGR of nearly 6.2% over the period from 2021 to 2028.
- Oncolytic Virus Immunotherapy Market - Global Industry Analysis: The global Oncolytic Virus Immunotherapy market accrued earnings worth approximately301 (USD Million) in 2020 and is predicted to gain revenue of about 678(USD Million) by 2028, is set to record a CAGR of nearly 12.1% over the period from 2021 to 2028.
- Animal Drug Compounding Market - Global Industry Analysis: The global Animal Drug Compounding market accrued earnings worth approximately 1.21(USD Billion) in 2020 and is predicted to gain revenue of about 3.31(USD Billion) by 2028, is set to record a CAGR of nearly 6.5% over the period from 2021 to 2028.
Browse through Zion Market Research's coverage of the Global Pharmaceutical Industry
Follow Us on: LinkedIn | Twitter | Facebook
About Us
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: [email protected]
Website: https://www.zionmarketresearch.com/
Blog : https://zmrblog.com/
Logo: https://mma.prnewswire.com/media/1605489/Zion_Market_Research_Logo.jpg
SOURCE Zion Market Research
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article